| dc.date.accessioned | 2023-03-06T07:33:24Z | |
| dc.date.available | 2023-03-06T07:33:24Z | |
| dc.date.issued | 2022 | |
| dc.identifier.citation | Rheumatol Int. 2022 Oct;42(10):1797-1806. doi: 10.1007/s00296-022-05134-z. Epub 2022 Apr 29. | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12619/100623 | |
| dc.relation.isversionof | 10.1007/s00296-022-05134-z | |
| dc.relation.isversionof | 10.1007/s00296-022-05134-z | |
| dc.title | Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all? | |
| dc.relation.journal | Rheumatol Int | |
| dc.identifier.doi | 10.1007/s00296-022-05134-z | |
| dc.contributor.author | İlgen U | |
| dc.contributor.author | İlgen U | |
| dc.contributor.author | Karadağ Ö | |
| dc.contributor.author | Emmungil H | |
| dc.contributor.author | Küçükşahin O | |
| dc.contributor.author | Koca SS | |
| dc.contributor.author | Erden A | |
| dc.contributor.author | Bes C |
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||